Search

Now showing items 1-6 of 6

Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

Jamme, Philippe; Fernandes, Marie; Copin, Marie-Christine; et al.
JOURNAL OF THORACIC ONCOLOGY, Lippincott, Williams & Wilkins, 31-05-2020, 15, 741 - 751

Compte-rendu et recension critique d'ouvragefulltext
Relevance of detection of mechanisms of resistance to alk inhibitors in alk-rearranged nsclc in routine practice

Jamme, Philippe; Descarpentries, Clotilde; Gervais, Radj; et al.
Clinical lung cancer, 26-02-2019

Article dans une revue scientifique
Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations

Jamme, Philippe; Fernandes, Marie; Copin, Marie-Christine; et al.
JOURNAL OF THORACIC ONCOLOGY, Lippincott, Williams & Wilkins, 31-05-2020, 15, 741 - 751

Article dans une revue scientifiquefulltext
Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the french pharmacovigilance database

Scanvion, Quentin; Bene, Johana; GAUTIER, Sophie; et al.
OncoImmunology, 01-01-2020, 9, 1722022

Article dans une revue scientifiquefulltext
Alterations in the pi3k pathway drive resistance to met inhibitors in nsclc harboring met exon 14 skipping mutations

Jamme, Philippe; Fernandes, Marie; Copin, Marie-Christine; et al.
Journal of thoracic oncology . official publication of the International Association for the Study of Lung Cancer, 10-03-2020

Article dans une revue scientifique
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Cortot, Alexis B.; Audigier-Valette, Clarisse; Molinier, Olivier; et al.
European Journal of Cancer, 05-2020, 131, 27-36

Article dans une revue scientifique